Apparent prevalence (HAST positive/all patients) | 0.36 (0.25–0.48) | 0.19 (0.10–0.30) |
True prevalence (ARAHE present/all patients) | 0.67 (0.55–0.77) | 0.69 (0.56–0.80) |
Sensitivity (TP/(TP+FN)) | 0.46 (0.32–0.61) | 0.25 (0.13–0.40) |
Specificity (TN/(TN+FP)) | 0.84 (0.64–0.95) | 0.95 (0.75–1.00) |
Positive predictive value (TP/(TP+FP)) | 0.85 (0.66–0.96) | 0.92 (0.62–1.00) |
Negative predictive value (TN/(TN+FN)) | 0.44 (0.29–0.59) | 0.37 (0.24–0.51) |
Positive likelihood ratio (sensitivity/1 − specificity) | 2.87 (1.12–7.41) | 5.00 (0.69–36.13) |
Negative likelihood ratio (1 − sensitivity/specificity) | 0.64 (0.47–0.87) | 0.79 (0.65–0.96) |
Proportion of correctly classified patients | 0.59 (0.47–0.70) | 0.47 (0.34–0.60) |